Bliss GVS Pharma Limited has informed the Exchange about Options to purchase securities
BLISSGVS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
On May 12, 2025, the Nomination and Remuneration Committee of Bliss GVS Pharma granted 8,62,000 stock options to eligible employees under the company's Employee Stock Options Plan 2019. Each option is convertible into one equity share of Re. 1 face value, at an exercise price of Rs. 43 per share, which represents a 61.62% discount to the NSE closing price on May 9, 2025. The options will vest in four equal installments of 25% each after 12, 24, 36, and 48 months from the grant date, with a 6-month exercise window after each vesting and a 6-month lock-in on shares issued post-exercise. The company also updated the scheme's references from the SEBI 2014 regulations to the newer 2021 regulations, while keeping all other terms unchanged.
This grant creates a potential dilution of up to 8,62,000 equity shares spread over four years, so existing shareholders should expect gradual share count expansion as options vest. The steep 61.62% discount to market price signals strong employee incentive but means new shares will come in at a much lower cost than market value.